Investing with top performing managers after a great run is probably a bad idea, according to a new study of long-term hedge fund performance.» Read More
Hedge fund manager Bill Ackman responds to criticism from Carl Icahn for his short position in Herbalife. Ackman also explains why he stands by Ron Johnson's vision for JC Penney.
Billionaire activist investors Carl Icahn and Bill Ackman are at it again.
David Einhorn's Greenlight Capital had a 2012 return of 7.9 percent, and a loss of 4.9 percent. CNBC's Herb Greenberg, offers insight.
CNBC's Kate Kelly reports David Einhorn of Greenlight Capital told investors shorts in iron ore miners hurt the results, not Herbalife.
Herbalife has been caught up in a battle royale with several notable money managers, so what's Cramer's take?
Bank of America has hit its lows of the day. Meanwhile CNBC's Herb Greenberg has an update on the Herbalife saga.
CNBC's David Faber reports Herbalife's updated preliminary fourth quarter and 2012 results.
Some of the names on the move ahead of the open.
Rumack: Can you fly this plane, and land it? Ted Striker: Surely you can't be serious. Rumack: I am serious... and don't call me Shirley. -Airplane Below, Boeing's Dreamliner woes become more serious, as the FAA temporarily grounds all 787 planes.
Billionaire Carl Icahn is telling other investors he has bought a stake in nutritional supplements seller Herbalife, according to a Dow Jones report on Wednesday.
According to the Dow Jones, Carl Icahn has taken a stake in Herbalife, reports CNBC's Herb Greenberg.
Take a look at some of Monday's midday movers:
Take a look at some of Friday's midday movers:
A fiscal-cliff driven sales boom in Malibu has made the California beach retreat the nation's likely leader for homes worth $10 million-plus.
Herbalife shares are attractive despite high-profile short interest in the stock, Kerrisdale Capital's Sahm Adrangi says.
Sahm Adrangi, Kerrisdale Capital Management, explains why he took a long position on Herbalife when the stock was trading at $26.
Herbalife's annual growth rate makes the stock attractive at its current level, Kerrisdale Capital Management Founder Sahm Adrangi says.
Stocks extended their gains in the final hour of trading to close near session highs Thursday, with all key S&P sectors finishing in positive territory, but volume was light amid caution ahead of next week's flurry of earnings report.
Herbalife ratcheted up its defense against activist investor Bill Ackman, with CNBC's Brian Shactman.
Herbalife is fighting back against Bill Ackman with an investor day today, reports CNBC's Herb Greenberg.